Jeff Auxier's BMY Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 21,900 shares of Bristol-Myers Squibb Company (BMY) worth $1.18 M, representing 0.17% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 51 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in BMY, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2020, adding 14,570 shares. Largest reduction occurred in Q4 2023, reducing 2,049 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Bristol-Myers Squibb Company (BMY) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bristol-Myers Squibb Company (BMY) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1,840 | Reduce 7.75% | 21,900 | $53.94 |
| Q3 2025 | +130 | Add 0.55% | 23,740 | $45.10 |
| Q2 2025 | -92 | Reduce 0.39% | 23,610 | $46.29 |
| Q1 2025 | -645 | Reduce 2.65% | 23,702 | $60.99 |
| Q4 2024 | -150 | Reduce 0.61% | 24,347 | $56.56 |
| Q3 2024 | -49 | Reduce 0.20% | 24,497 | $51.74 |
| Q2 2024 | -624 | Reduce 2.48% | 24,546 | $41.53 |
| Q1 2024 | -1,604 | Reduce 5.99% | 25,170 | $54.23 |
| Q4 2023 | -2,049 | Reduce 7.11% | 26,774 | $51.31 |
| Q3 2023 | -50 | Reduce 0.17% | 28,823 | $58.04 |
| Q2 2023 | -74 | Reduce 0.26% | 28,873 | $63.95 |
| Q1 2023 | -300 | Reduce 1.03% | 28,947 | $69.31 |
| Q3 2022 | -849 | Reduce 2.82% | 29,247 | $71.08 |
| Q2 2022 | -999 | Reduce 3.21% | 30,096 | $76.99 |
| Q1 2022 | +75 | Add 0.24% | 31,095 | $73.03 |
| Q4 2021 | +1 | Add 0.00% | 31,020 | $62.35 |
| Q3 2021 | -49 | Reduce 0.16% | 31,019 | $59.16 |
| Q2 2021 | -539 | Reduce 1.71% | 31,068 | $66.82 |
| Q1 2021 | -402 | Reduce 1.26% | 31,607 | $63.12 |
| Q4 2020 | +14,570 | Add 83.55% | 32,009 | $62.05 |
| Q3 2020 | +1,233 | Add 7.61% | 17,439 | $60.27 |
| Q2 2020 | +9,181 | Add 130.69% | 16,206 | $58.81 |
| Q1 2020 | +645 | Add 10.11% | 7,025 | $55.80 |
| Q4 2019 | +311 | Add 5.12% | 6,380 | $64.26 |
| Q3 2019 | +150 | Add 2.53% | 6,069 | $50.75 |
| Q2 2019 | +75 | Add 1.28% | 5,919 | $45.28 |
| Q1 2019 | -1,200 | Reduce 17.04% | 5,844 | $47.74 |
| Q4 2018 | -225 | Reduce 3.10% | 7,044 | $51.96 |
| Q2 2018 | -124 | Reduce 1.68% | 7,269 | $55.30 |
| Q1 2018 | +1,000 | Add 15.64% | 7,393 | $63.30 |
| Q2 2017 | -1,000 | Reduce 13.53% | 6,393 | $55.69 |
| Q1 2017 | +2,700 | Add 57.53% | 7,393 | $54.38 |
| Q3 2016 | -300 | Reduce 6.01% | 4,693 | $53.91 |
| Q1 2016 | +50 | Add 1.01% | 4,993 | $63.89 |
| Q4 2015 | -100 | Reduce 1.98% | 4,943 | $68.78 |
| Q2 2014 | -739 | Reduce 12.78% | 5,043 | $48.58 |
| Q2 2013 | +5,783 | Add 0.00% | 5,782 | $44.62 |
Jeff Auxier's Bristol-Myers Squibb Company Investment FAQs
Jeff Auxier first purchased Bristol-Myers Squibb Company (BMY) in Q2 2013, acquiring 5,782 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Bristol-Myers Squibb Company (BMY) for 51 quarters since Q2 2013.
Jeff Auxier's largest addition to Bristol-Myers Squibb Company (BMY) was in Q4 2020, adding 32,009 shares worth $1.99 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 21,900 shares of Bristol-Myers Squibb Company (BMY), valued at approximately $1.18 M.
As of the Q4 2025 filing, Bristol-Myers Squibb Company (BMY) represents approximately 0.17% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Bristol-Myers Squibb Company (BMY) was 32,009 shares, as reported at the end of Q4 2020.